Ge Healthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has forty-nine approved drugs.
There are six US patents protecting GE HEALTHCARE drugs.
There are seventy-nine patent family members on GE HEALTHCARE drugs in twenty-five countries and one hundred and twenty-eight supplementary protection certificates in eighteen countries.
Summary for Ge Healthcare
International Patents: | 79 |
US Patents: | 6 |
Tradenames: | 57 |
Ingredients: | 38 |
NDAs: | 49 |
Drug Master File Entries: | 5 |
Drugs and US Patents for Ge Healthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | VIZAMYL | flutemetamol f-18 | INJECTABLE;INTRAVENOUS | 203137-002 | Oct 25, 2013 | RX | Yes | Yes | 7,270,800 | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
Ge Healthcare | TELEPAQUE | iopanoic acid | TABLET;ORAL | 008032-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Ge Healthcare | HYPAQUE-CYSTO | diatrizoate meglumine | SOLUTION;URETHRAL | 016403-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Ge Healthcare | AMERSCAN MDP KIT | technetium tc-99m medronate kit | INJECTABLE;INJECTION | 018335-001 | Aug 5, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Ge Healthcare | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 017256-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ge Healthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | MPI DMSA KIDNEY REAGENT | technetium tc-99m succimer kit | INJECTABLE;INJECTION | 017944-001 | May 18, 1982 | 4,233,285 | See Plans and Pricing |
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 020123-001 | Jan 8, 1993 | 5,560,903 | See Plans and Pricing |
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020808-001 | Aug 29, 1997 | 5,366,722 | See Plans and Pricing |
Ge Healthcare | OMNISCAN | gadodiamide | INJECTABLE;INJECTION | 022066-001 | Sep 5, 2007 | 5,560,903 | See Plans and Pricing |
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | 5,349,085 | See Plans and Pricing |
Ge Healthcare | CERETEC | technetium tc-99m exametazime kit | INJECTABLE;INJECTION | 019829-001 | Dec 30, 1988 | 4,615,876 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Ge Healthcare Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 0113470 | See Plans and Pricing |
Hungary | S1500007 | See Plans and Pricing |
Australia | 2011200667 | See Plans and Pricing |
European Patent Office | 2182988 | See Plans and Pricing |
Brazil | PI0408274 | See Plans and Pricing |
Canada | 2438032 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ge Healthcare Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2182988 | 2015006 | Norway | See Plans and Pricing | PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822 |
2957286 | 2018/046 | Ireland | See Plans and Pricing | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
2563920 | CA 2019 00001 | Denmark | See Plans and Pricing | PRODUCT NAME: A COMPOUND COMPRISING A MODIFIED OLIGONUCLEOTIDE HAVING A NUCLEOBASE SEQUENCE CONSISTING OF 20 LINKED NUCLEOSIDES ACCORDING TO EP B1 2563920 CLAIM 1 (SEQ ID NO: 80), ...SPECIFICALLY INOTERSEN; AND ITS DERIVATIVES, INCLUDING SODIUM SALTS ...; REG. NO/DATE: EU/1/18/1296 20180710 |
2822954 | 18C1035 | France | See Plans and Pricing | PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625 |
1874117 | SPC/GB14/041 | United Kingdom | See Plans and Pricing | PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTERED: UK EU/1/13/892/001-006 20140121 |
0290047 | SPC/GB97/078 | United Kingdom | See Plans and Pricing | PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.